These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 21110118)
1. Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus. Shahsavandi S; Salmanian AH; Ghorashi SA; Masoudi S; Fotouhi F; Ebrahimi MM Mol Biol Rep; 2011 Jun; 38(5):3293-8. PubMed ID: 21110118 [TBL] [Abstract][Full Text] [Related]
2. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Johansson BE Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609 [TBL] [Abstract][Full Text] [Related]
3. Baculovirus surface display of the HA protein of H5N2 avian influenza virus and its immunogenicity against a lethal challenge with H5N1 virus in chickens. Tung MC; Lu HY; Chang YK; Huang WR; Liao TL; Wu HY; Chang CD; Fan HC; Nielsen BL; Liu HJ Vet Microbiol; 2020 Apr; 243():108640. PubMed ID: 32273019 [TBL] [Abstract][Full Text] [Related]
4. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Lee CW; Senne DA; Suarez DL Clin Vaccine Immunol; 2006 Mar; 13(3):395-402. PubMed ID: 16522783 [TBL] [Abstract][Full Text] [Related]
5. Development of hemagglutinin subtype-specific reference antisera by DNA vaccination of chickens. Lee CW; Senne DA; Suarez DL Avian Dis; 2003; 47(3 Suppl):1051-6. PubMed ID: 14575109 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens. Choi JG; Kim MC; Kang HM; Kim KI; Lee KJ; Park CK; Kwon JH; Kim JH; Lee YJ Vet Microbiol; 2013 Mar; 162(2-4):623-630. PubMed ID: 23265240 [TBL] [Abstract][Full Text] [Related]
8. Prime-Boost Vaccination With a Novel Hemagglutinin Protein Produced in Bacteria Induces Neutralizing Antibody Responses Against H5-Subtype Influenza Viruses in Commercial Chickens. Sączyńska V; Romanik-Chruścielewska A; Florys K; Cecuda-Adamczewska V; Łukasiewicz N; Sokołowska I; Kęsik-Brodacka M; Płucienniczak G Front Immunol; 2019; 10():2006. PubMed ID: 31552018 [TBL] [Abstract][Full Text] [Related]
9. WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. He F; Ho Y; Yu L; Kwang J BMC Microbiol; 2008 Dec; 8():238. PubMed ID: 19116038 [TBL] [Abstract][Full Text] [Related]
10. Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus. Pedersen JC Methods Mol Biol; 2014; 1161():11-25. PubMed ID: 24899416 [TBL] [Abstract][Full Text] [Related]
11. Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes. Mueller M; Renzullo S; Brooks R; Ruggli N; Hofmann MA PLoS One; 2010 Feb; 5(2):e9097. PubMed ID: 20140098 [TBL] [Abstract][Full Text] [Related]
12. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
13. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens. Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. Loureiro S; Ren J; Phapugrangkul P; Colaco CA; Bailey CR; Shelton H; Molesti E; Temperton NJ; Barclay WS; Jones IM J Virol; 2011 Mar; 85(6):3010-4. PubMed ID: 21191017 [TBL] [Abstract][Full Text] [Related]
15. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Brett IC; Johansson BE Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702 [TBL] [Abstract][Full Text] [Related]
16. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102 [TBL] [Abstract][Full Text] [Related]
17. Development of neuraminidase subtype-specific reference antisera by recombinant protein expressed in baculovirus. Lee KJ; Choi JG; Kang HM; Kim KI; Park CK; Lee YJ Clin Vaccine Immunol; 2013 Feb; 20(2):140-5. PubMed ID: 23221001 [TBL] [Abstract][Full Text] [Related]
18. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice. Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133 [TBL] [Abstract][Full Text] [Related]
19. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Tang XC; Lu HR; Ross TM Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393 [TBL] [Abstract][Full Text] [Related]
20. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]